PH12013502323A1 - Dry-coated tablet containing tegafur, gimeracil and oteracil potassium - Google Patents

Dry-coated tablet containing tegafur, gimeracil and oteracil potassium

Info

Publication number
PH12013502323A1
PH12013502323A1 PH1/2013/502323A PH12013502323A PH12013502323A1 PH 12013502323 A1 PH12013502323 A1 PH 12013502323A1 PH 12013502323 A PH12013502323 A PH 12013502323A PH 12013502323 A1 PH12013502323 A1 PH 12013502323A1
Authority
PH
Philippines
Prior art keywords
gimeracil
dry
coated tablet
oteracil potassium
tablet containing
Prior art date
Application number
PH1/2013/502323A
Other languages
English (en)
Inventor
Yoshito Ohnishi
Takumi Okamoto
Takashi Yoshizawa
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of PH12013502323A1 publication Critical patent/PH12013502323A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH1/2013/502323A 2011-05-25 2012-05-24 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium PH12013502323A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011116884 2011-05-25
PCT/JP2012/063260 WO2012161240A1 (ja) 2011-05-25 2012-05-24 テガフール、ギメラシル、オテラシルカリウム含有有核錠

Publications (1)

Publication Number Publication Date
PH12013502323A1 true PH12013502323A1 (en) 2014-01-06

Family

ID=47217314

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/502323A PH12013502323A1 (en) 2011-05-25 2012-05-24 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium

Country Status (16)

Country Link
US (1) US20140335174A1 (https=)
EP (1) EP2716290B1 (https=)
JP (2) JP5689173B2 (https=)
KR (2) KR101869127B1 (https=)
AU (1) AU2012259803B2 (https=)
BR (1) BR112013030093B1 (https=)
CA (1) CA2836865C (https=)
ES (1) ES2671926T3 (https=)
IL (1) IL229372B (https=)
MX (1) MX353289B (https=)
MY (1) MY167883A (https=)
PH (1) PH12013502323A1 (https=)
RU (1) RU2601620C2 (https=)
SG (2) SG194922A1 (https=)
TW (2) TWI566787B (https=)
WO (1) WO2012161240A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012161240A1 (ja) * 2011-05-25 2012-11-29 大鵬薬品工業株式会社 テガフール、ギメラシル、オテラシルカリウム含有有核錠
CN107837273A (zh) * 2016-09-18 2018-03-27 江苏金甙生物技术有限公司 一种肠溶替吉奥缓释制剂及其制备方法
CN107865871B (zh) * 2016-09-23 2021-09-03 江苏恒瑞医药股份有限公司 一种替吉奥组合物及其制备方法
CN106619689B (zh) * 2016-12-30 2018-05-01 陈晓华 一种用于治疗癌症的药物组合物、试剂盒及其应用
EP4029380B1 (en) * 2019-09-13 2026-01-28 Meiji Co., Ltd Solid milk
JPWO2023238929A1 (https=) * 2022-06-10 2023-12-14

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021345A1 (en) 1991-05-27 1992-12-10 Taiho Pharmaceutical Co., Ltd. Composition, method and kit for potentiating antitumor activity and for curing tumor
CA2322315C (en) * 1998-03-06 2008-09-16 Eurand International S.P.A. Fast disintegrating tablets
CA2408956C (en) * 2000-05-18 2011-07-12 Therics, Inc. Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
US20050202082A1 (en) * 2001-09-28 2005-09-15 Tsuneyuki Hibino Press-coated molded article undergoing quick disintegration
JP2005512997A (ja) * 2001-11-07 2005-05-12 シントン・ベスローテン・フェンノートシャップ タムスロシン錠
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
JP4610481B2 (ja) * 2003-03-14 2011-01-12 大鵬薬品工業株式会社 抗腫瘍効果増強剤及び抗腫瘍剤
CA2540488A1 (en) * 2003-09-29 2005-04-07 Cipla Limited Pharmaceutical formulation with improved stability
CN100333726C (zh) 2004-12-23 2007-08-29 鲁南制药集团股份有限公司 含有替加氟、吉莫斯特和氧嗪酸钾的口腔崩解片
DE602006016576D1 (de) * 2005-04-01 2010-10-14 Taiho Pharmaceutical Co Ltd Strahlentherapieverstärker
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
MY151207A (en) * 2007-12-27 2014-04-30 Taiho Pharmaceutical Co Ltd Oral particulate antitumor preparation
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
KR100934876B1 (ko) 2008-01-31 2010-01-06 성균관대학교산학협력단 Ｌｉｇａ공정의 도금방법
CN101380327B (zh) * 2008-10-09 2011-01-26 北京恒瑞康达医药科技发展有限公司 抗癌复合缓释组合物及制备
JP5553522B2 (ja) 2009-03-31 2014-07-16 大鵬薬品工業株式会社 経口投与用医薬組成物
EP2431032A4 (en) * 2009-05-12 2012-11-07 Taiho Pharmaceutical Co Ltd ANTICROBIAL AGENTS WITH A TEGAFUR GIMERACIL OTERACIL CALIUM COMBINATION AND OXALIPLATIN
CN101711765B (zh) * 2009-10-31 2011-03-23 山东新时代药业有限公司 一种含有替加氟、吉美嘧啶和奥替拉西钾的分散片
WO2012161240A1 (ja) * 2011-05-25 2012-11-29 大鵬薬品工業株式会社 テガフール、ギメラシル、オテラシルカリウム含有有核錠
CN102614183B (zh) * 2012-03-05 2013-10-30 齐鲁制药(海南)有限公司 一种替吉奥的口服制剂

Also Published As

Publication number Publication date
CA2836865A1 (en) 2012-11-29
EP2716290A4 (en) 2014-11-26
TW201300141A (zh) 2013-01-01
RU2601620C2 (ru) 2016-11-10
TWI488659B (zh) 2015-06-21
ES2671926T3 (es) 2018-06-11
KR20170072959A (ko) 2017-06-27
MY167883A (en) 2018-09-26
MX353289B (es) 2018-01-05
TWI566787B (zh) 2017-01-21
US20140335174A1 (en) 2014-11-13
IL229372B (en) 2018-12-31
MX2013013563A (es) 2013-12-16
JP5769853B2 (ja) 2015-08-26
EP2716290B1 (en) 2018-03-14
BR112013030093A2 (pt) 2016-09-20
BR112013030093B1 (pt) 2019-12-10
AU2012259803B2 (en) 2016-03-17
KR101869127B1 (ko) 2018-06-19
JP5689173B2 (ja) 2015-03-25
EP2716290A1 (en) 2014-04-09
SG194922A1 (en) 2013-12-30
KR20140037879A (ko) 2014-03-27
CA2836865C (en) 2018-02-27
NZ617625A (en) 2015-10-30
IL229372A0 (en) 2014-01-30
TW201529100A (zh) 2015-08-01
JP2014218523A (ja) 2014-11-20
RU2013157528A (ru) 2015-06-27
WO2012161240A1 (ja) 2012-11-29
JPWO2012161240A1 (ja) 2014-07-31
SG10201505503WA (en) 2015-09-29

Similar Documents

Publication Publication Date Title
MX347260B (es) Encapsulados.
MY167883A (en) Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
EA201170271A1 (ru) Микрокапсулы, содержащие активные ингредиенты и оболочку из оксида металла, способ их получения и их применения
PH12013501345A1 (en) Tamper resistant solid oral dosage forms
GB201106750D0 (en) Novel compounds
SI3172964T1 (sl) Sestavki proti parazitom, ki obsegajo izoksazolinsko aktivno sredstvo, postopek in njihove uporabe
UA114595C2 (uk) Гербіцидні суспензії капсул ацетохлору, що містять знижені кількості антидоту
PH12015500900B1 (en) A stabilized pemetrexed formulation
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
AP2012006232A0 (en) New association between 4-ä3-ÄCIS-hexahydrocyclopentaÄcÜpyrrol-2(1H)-YLÜpropoxyübenzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
NZ612722A (en) Hop extract oxidation-reaction product, preparing method thereof and use thereof
AU2012259803A1 (en) Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
PH12013501552A1 (en) Oral care compositions
PH12016500174A1 (en) Combination formulation containing sustained release metformin and immediate release hmg-coa reductase inhibitor
WO2013056888A3 (en) Hair styling composition
EA201301355A1 (ru) Композиция и таблетка, содержащая ралтегравир
PH12013502418A1 (en) Tablet comprising limaprost and b-cyclodextrin
PL394619A1 (pl) Sposób proteolizy, peptydaza, kompozycja do stosowania jako srodek bakteriostatyczny lub bakteriobójczy, zestaw oraz zastosowania aktywnej formy LytM z S. aureus lub jej pochodnej
PH12015500469A1 (en) High dose extended-release potassium citrate wax matrix tablet
WO2013124832A3 (en) Stabilized controlled-release pharmaceutical composition comprising gliclazide
MX366768B (es) Tableta orodispersable de sildenafil y metodo para preparar la misma.
UA73620U (uk) Засіб для зупинки кровотечі "желпластан"
UA65707U (en) Enamel
GB201105096D0 (en) Effervescent nootropic supplement tablet. Powdered cognitive enhancing effervescent tablet supplement including various nootropic compounds, including but not
TH146317A (th) ยาเม็ดชนิดเคลือบแบบแห้งที่มีทีกาเฟอร์ จิมีราซิล และโอทีราซิลโปแตสเซียม